As GWAS of sporadic PD patients have repeatedly identified risk polymorphisms in the MAPT locus encoding tau proteins [11,12,94,95], and because PD patients with LRRK2 mutations sometimes show tau accumulation [19,96,97], tau is thought to be one of the most pathologically relevant substrates. This evidence concerns the gene LRRK2 and Parkinson disease.